Carsten Maschmeyer convinces professional soccer player of his start-up
Janina Gerhardt
| 20.10.2022
HMNC wants to provide individualized treatment for people with depression. Now well-known investors are getting on board.
Holsboer Maschmeyer Neurochemie (HMNC) raised €14.3 million in the first of two planned closings, as Gründerszene reported. Carsten Maschmeyer is founder and shareholder of the company and invests again in the current round. Soccer star Toni Kroos is also investing. Josef Ackermann, former CEO of Deutsche Bank, is also participating in the current round.
Kroos invested in the start-up, he said, because mental health is also an issue in competitive sports. "There, of course, the topic of mental health is also present and is still partly underestimated, although the physical and also the psychological pressure is enormously high," Kroos is quoted by Gründerszene.
With the new capital, HMNC wants to further develop its program for precision psychiatry. With the application, it should be possible to treat people with depression more individually. Founded in 2010, the company has received 42.3 million in financing since its launch.
Newsletter
Startups, stories and stats from the German startup ecosystem straight to your inbox. Subscribe with 2 clicks. Noice.
LinkedIn ConnectTake care, give care
Did this news inform or entertain you? Then we would be happy if you tell your network about it.
Share on Linkedin Share on Facebook Share on XingFYI: English edition available
Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?
FYI: Deutsche Edition verfügbar
Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?
